SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-21 4:39 PM View: | Tyra Biosciences, Inc. (TYRA) | 17-Sep-21 | Conversion Duplicate | 4,409,990 | -- | -- | 16333% 27.0K to 4.44M | |
11-Dec-17 3:25 PM View: | Tranzyme, Inc. (OCRX) | 11-Dec-17 | Disposition | 12,500 | $1.52 | $19,000.00 | (100%) 12.5K to 0 | |
22-Jun-17 4:40 PM View: | Tranzyme, Inc. (OCRX) | 20-Jun-17 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
22-Apr-15 2:45 PM View: | Cidara Therapeutics, Inc. (CDTX) | 20-Apr-15 | Conversion | 1,156,810 | -- | -- | 100% 0 to 1.16M | |
22-Apr-15 2:45 PM View: | Cidara Therapeutics, Inc. (CDTX) | 20-Apr-15 | Purchase | 200,000 | $16.00 | $3,200,000.00 | 17% 1.16M to 1.36M | |
12-Nov-13 5:27 PM View: | Tranzyme, Inc. (OCRX) | 08-Nov-13 | Purchase | 422,238 | -- | -- | 51% 825.82K to 1.25M | |
17-Jul-13 4:12 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Grant | 394,391 | -- | -- | 100% 0 to 394.39K | |
17-Jul-13 4:12 PM View: | Tranzyme, Inc. (OCRX) | 15-Jul-13 | Purchase | 431,435 | $6.03 | $2,600,000.00 | 109% 394.39K to 825.83K | |
10-Aug-10 1:50 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Conversion Duplicate | 2,321,310 | $1.40 | $3,260,890.00 | 60% 3.9M to 6.22M | |
10-Aug-10 1:50 PM View: | Trius Therapeutics Inc (TSRX) | 06-Aug-10 | Purchase Duplicate | 1,227,330 | $5.00 | $6,136,660.00 | 20% 6.22M to 7.45M |